Skip to main content
Exact Sciences Corporation (EXAS)
NASDAQ: EXAS · Real-Time Price · USD
103.38
+0.13 (0.13%)
At close: Feb 27, 2026, 4:00 PM EST
103.32
-0.06 (-0.06%)
After-hours: Feb 27, 2026, 7:30 PM EST

Exact Sciences Revenue

In the year 2025, Exact Sciences had annual revenue of $3.25B with 17.69% growth. Exact Sciences had revenue of $878.38M in the quarter ending December 31, 2025, with 23.12% growth.

Revenue (ttm)
$3.25B
Revenue Growth
+17.69%
P/S Ratio
6.08
Revenue / Employee
$450,971
Employees
7,200
Market Cap
19.73B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20253.25B488.12M17.69%
Dec 31, 20242.76B259.10M10.37%
Dec 31, 20232.50B415.49M19.93%
Dec 31, 20222.08B317.19M17.95%
Dec 31, 20211.77B275.70M18.49%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
IQVIA Holdings 16.31B
Labcorp Holdings 13.95B
Quest Diagnostics 11.04B
Agilent Technologies 7.07B
Illumina 4.34B
Mettler-Toledo International 4.03B
Waters 3.17B
Revvity 2.86B
Revenue Rankings

EXAS News

More News